Design and evaluation of colon targeted modified pulsincap delivery of 5-fluorouracil according to circadian rhythm
{{output}}
Introduction: A modified pulsincap dosage form of 5-fluorouracil was developed to target drug to colorectal carcinoma according to daily oscillations of rate-limiting metabolizing enzyme dihydropyrimidine dehydrogenase. ... ...
